ClinicalTrials.gg
RecruitingNCT07193303Updated Jul 14, 2026

Mental Imagery on Upper Extremity Skills

An interventional study of mental imagination in PARKINSON DISEASE (Disorder), Mental Imagery and Motor Imagery, sponsored by Kahramanmaras Sutcu Imam University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-07-14.

Sponsored by Kahramanmaras Sutcu Imam University · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
40 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 172 studies in Parkinson Disease with a site in Turkey — 50 open to participants now, 56 under way, none of them phase 3. Parkinson Disease · Turkey.

Planned enrollment
56th of 99
30 · median 32
Started
2026
with 28 others
No phase
92 of 172
26 open now
Primary completion
2026-12
later than 37 of 55 live
Registered
122nd of 172
by date
Lead sponsor
4 of 172
Kahramanmaras Sutcu Imam University

Among the 172 studies in Parkinson Disease with a site in Turkey, this one is the 56th largest by planned enrollment of the 99 interventional ones that give a count, is one of 29 that started in 2026, is one of 92 with no phase, reaches primary completion later than 37 of the 55 other live ones, and was the 122nd registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

50 of the 172 studies in Parkinson Disease with a site in Turkey are open now. Recruiting first, the newest first:

44 more — sign in →

All 50 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 40 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 172 studies in Parkinson Disease with a site in Turkey, or all of them as a file.
02

Study summary

Parkinson's disease (PD) is the second most common neurodegenerative disease, characterized pathologically by the progressive loss of dopaminergic neurons in the substantia nigra and clinically by the presence of motor symptoms such as bradykinesia, resting tremor, and/or rigidity. Among the motor deficits frequently observed in PD, patients are known to frequently report difficulties with manual dexterity. Many upper extremity and manual dexterity deficits are present in PD. Motor imagery (MI) is the imaginal execution of motor activities or the activation of specific muscles in the absence of any explicit feedback. This area of rehabilitation has been shown to be effective in improving and developing motor skills in many neurological conditions where patients exhibit motor recognition and execution impairments. MI can be applied at all stages of recovery from PD, is highly effective in movement-related pathologies, and can be performed independently.There is sufficient evidence that MI improves motor performance and learning in individuals with neurological disorders such as multiple sclerosis, stroke, and spinal cord injury. The study was designed to investigate the immediate effects of mental imagery, which is thought to be effective in controlling difficulties in planning and initiating movements in PD, on upper extremity skills. Therefore, the aim of this study was to determine the effect of mental imagery on upper extremity skills in PD.

03

Conditions studied

  • PARKINSON DISEASE (Disorder)
  • Mental Imagery
  • Motor Imagery

Browse trials for

04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy individuals aged 40-75 years, diagnosed with idiopathic PD according to the UK Parkinson's Disease Association Brain Bank criteria by a specialist neurologist, with a Modified Hoehn \& Yahr (m-HY) scale stage ≤4, and with a score of ≥24 for those with training and ≥18 for those without training, and with no known disease, volunteered to participate in the study.
  • PD individuals with no other known neurological and/or systemic disease
  • PD individuals without any upper extremity contractures

Exclusion criteria

Exclusion Criteria:

  • Individuals with diagnosed and/or treated psychiatric illnesses who are considered unable to complete the tests.
  • Individuals who is taking neuroleptic medications or antidepressants.
  • Individuals with orthopedic conditions that interfere with manual dexterity tests, such as severe dyskinesia, carpal tunnel syndrome, tendon injuries, or finger amputations; rheumatological conditions such as rheumatoid arthritis and osteoarthritis; and individuals with any neurological condition other than PD.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    1/study group

    Upper extremity skill tests will be performed on individuals diagnosed with idiopathic Parkinson's disease and recorded with a mental stopwatch using mental imagery.

    Other: mental imagination

  • No intervention
    2/control group

    Upper extremity skill tests will be performed on individuals diagnosed with idiopathic Parkinson's disease.

Interventions

  • Othermental imagination

    The Nine-Hole Peg Test (9 DPT) will be performed with a mental chronometer.the duration between actually physically performing the movement and mentally imagining the same movement will be recorded.

06

What researchers measure

Primary outcomes

  1. The Nine-Hole Peg Test (9PPT) with Mental Chronometry

    Mental Chronometry: Mental chronometry is a method that measures imagery time, considered more objective than questionnaires in the assessment of MI. It examines the time difference between the actual physical execution of a movement and the mental image of the same movement. The Nine-Hole Peg Test (9PPT) is frequently used in the literature, although its validity and reliability as a mental chronometry test are lacking. In this task, the participant is required to remove nine pegs from the board to which they are fixed as quickly as possible and place them in a container on the board. The pegs used in the test (8 mm in diameter, 3 cm long) can be made of wood or plastic. The board (23 cm long, 10 cm wide, and 2 cm high) has a section at one end where the pegs are fixed (arranged in a 3x3 matrix) and a container-shaped space on the side for the pegs to be placed. Participants perform the test on both upper extremities. Before the test, all participants are given the opportunity to ho

    Time frame: first day of the assesment

Secondary outcomes

  1. sosyodemographic form

    Medical history (disease duration and symptoms), demographic information, will be recorded.

    Time frame: first day of the assesment

  2. Modified Hoehn & Yahr (m-HY) scale

    PD disability will be assessed with the m-HY scale. All of the patients with PD will be staged according to the Hoehn Yahr scale as follows: stage 1.0 (unilateral involvement only); stage 1.5 (unilateral and axial involvement); stage 2.0 (bilateral involvement without balance impairment); stage 2.5 (mild bilateral disease with improvement in the pull test); stage 3.0 (mild to moderate bilateral disease; some postural impairment; physically independent); stage 4.0 (severe disability; still able to walk or stand unaided).

    Time frame: first day of the assesment

  3. Unified Parkinson's Disease Rating Scale (UPDRS)

    Symptom severity in PD is rated using the Unified Parkinson's Disease Rating Scale (UPDRS). Several items on this scale assess upper extremity and hand function. The Activities of Daily Living section assesses handwriting, cutting food, and grasping utensils. The Motor section assesses finger tapping, hand movements, and rapid alternating hand movements. These test items are scored from 0 to 4, with 4 representing maximum impairment and 0 representing normal movement ability. The UPDRS sections are subdivided into: Section I (mental dysfunction and mood); Section II (activities of daily living); Section III (motor); and Section IV (treatment-related complications).

    Time frame: first day of the asessment

  4. Mini Mental State Examination (MMSE)

    This test was developed by Folstein in 1975. Its Turkish validity and reliability study was conducted by Güngen et al. in 2002. The MMSE, which is quite suitable for screening cognitive function in the elderly and assesses cognitive functions in five separate areas (orientation, registration, attention and calculation, recall, and language), is frequently used. A score below 24 on the MMSE indicates dementia, 24-26 indicates mild cognitive impairment, and 26 or above indicates normal cognitive function.

    Time frame: first day of the assessment

  5. Muscle Strength Measurement

    Isometric strength will be measured using a digital muscle strength measurement device (KFORCE KINVENT) for the bilateral serratus anterior, upper trapezius, latissimus dorsi, deltoid, supraspinatus, teres minor, subscapularis, and biceps brachii muscles of the upper extremity.

    Time frame: first day of the assesment

  6. Grip Strength Measurement

    A Jamar hand dynamometer (Baseline®) (and a PinchMeter (Baseline Mechanical Pinch Gauge with Case, Blue, 30 lb) will be used for grip strength measurement.

    Time frame: first day of the assesment

  7. The Kinesthetic and Visual Imagery Questionnaire (KVIQ)

    The Kinesthetic and Visual Imagery Questionnaire (KVIQ), Short Form, was developed to determine the extent to which individuals visualize and feel imaged movements. It consists of a total of 10 movements measuring five visual and five kinesthetic imagery skills (23). The questionnaire is not a self-report measure but is administered by an assessor. All movements are assessed in a sitting position. The assessor first performs the relevant movement on themselves, and then the participant is asked to perform the same movement only once. The participant then imagines the movement and is asked to rate the visual clarity or intensity of sensations of the imagined movement using a five-point ordinal scale. Higher scores indicate greater visual clarity or intensity of sensations. This questionnaire will be used to assess mental imagery ability in our study.

    Time frame: first day of the assesment

07

Study locations

1 of 1 sites recruiting
  • Kahramanmaraş Sütçü imam University
    Kahramanmaraş, Onikişubat 46100, Turkey (Türkiye)
    Recruiting
    • Asiya Uzun, assistant professor · Contactasiyeaycicek@gmail.com · +903443002621
    • Hatice adıgüzel tat, Associate Professor · Sub investigator
    • Asiya uzun, Asisstant Prof · Principal investigator
    • Yusuf Şinasi Kırmacı, Asisstant Prof · Sub investigator
    • Abdulkadir Ertürk, Msc · Sub investigator
    • Tuğçe Simay Özbay, Msc · Sub investigator
    • Buket Tuğan Yıldız, Associate Professor · Sub investigator
    • Deniz Tuncel Berktaş, Proffessor · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for Dec 2026, 7 months after the start.

Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 7 months is below that.

Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 12, 2025
First posted
Sep 25, 2025
StartActual
May 15, 2026
Primary completionEst.
Dec 15, 2026
CompletionEst.
Jan 30, 2027
Last update
Jul 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07193303
Responsible party
Hatice Adiguzel (Associate Profesor, Kahramanmaras Sutcu Imam University) — Principal investigator
First posted
Sep 25, 2025
Start date
May 15, 2026
Primary completion
Dec 15, 2026 (estimated)
Completion
Jan 30, 2027 (estimated)
Last update
Jul 14, 2026

Study contacts

Hatice adıgüzel tat, Associate Proffessor
Contact
fzthatis@gmail.com
+903443002647
hatice Adiguzel tat, Associate Proffessor
Contact
fzthatis@gmail.com
+903443002647
hatice adıgüzel tat, Associate Professor
study chair · Kahramanmaras Sutcu Imam University
Asiya Uzun, Asisstant Prof
principal investigator · Kahramanmaras Sutcu Imam University
Yusuf Şinasi Kırmacı, Asisstant Prof
study chair · Kahramanmaras Sutcu Imam University
Abdulkadir Ertürk, Msc
study chair · Kahramanmaras Sutcu Imam University
Tuğçe Simay Özbay, Msc
study chair · Kahramanmaras Sutcu Imam University
Buket Tuğan Yıldız, Associate Professor
study chair · Kahramanmaras Sutcu Imam University
Deniz Tuncel, Proffessor
study chair · Kahramanmaras Sutcu Imam University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion